Boston Scientific gains approval for asthma device in China

10/25/2013 | (Boston)

Chinese regulators have granted Boston Scientific approval to market its Alair Bronchial Thermoplasty device in that country. The device, which the company acquired through its $193.5 million purchase of Asthmatx in 2010, is designed to treat severe asthma patients who have failed to respond to long-acting beta-agonists or inhaled corticosteroids.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA